BDX vs COR · P/E 34, rev $21.84B vs P/E 21, rev $321.33B
Becton Dickinson and Company (BDX) versus Cencora Inc. (COR) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Not investment advice. Open the BDX and COR stock pages for the full models.
Not investment advice.